Prevalence of cardiovascular disease and its influencing factors among the Uygur population in rural areas of Xinjiang

WANG Yuxiang; MA Rulin; GUO Heng; ZHANG Xianghui; HE Jia; WANG Xinping; HU Yunhua; MA Jiaolong; GUO Shuxia

doi:10.16462/j.cnki.zhjbkz.2023.04.003

Volume 27 Issue 4

Apr. 2023

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2023 > 27(4): 385-391

WANG Yuxiang, MA Rulin, GUO Heng, ZHANG Xianghui, HE Jia, WANG Xinping, HU Yunhua, MA Jiaolong, GUO Shuxia. Prevalence of cardiovascular disease and its influencing factors among the Uygur population in rural areas of Xinjiang[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(4): 385-391. doi: 10.16462/j.cnki.zhjbkz.2023.04.003

Citation:

WANG Yuxiang, MA Rulin, GUO Heng, ZHANG Xianghui, HE Jia, WANG Xinping, HU Yunhua, MA Jiaolong, GUO Shuxia. Prevalence of cardiovascular disease and its influencing factors among the Uygur population in rural areas of Xinjiang[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(4): 385-391. doi: 10.16462/j.cnki.zhjbkz.2023.04.003

Citation:

WANG Yuxiang, MA Rulin, GUO Heng, ZHANG Xianghui, HE Jia, WANG Xinping, HU Yunhua, MA Jiaolong, GUO Shuxia. Prevalence of cardiovascular disease and its influencing factors among the Uygur population in rural areas of Xinjiang[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(4): 385-391. doi: 10.16462/j.cnki.zhjbkz.2023.04.003

PDF( 854 KB)

Prevalence of cardiovascular disease and its influencing factors among the Uygur population in rural areas of Xinjiang

doi: 10.16462/j.cnki.zhjbkz.2023.04.003

Department of Preventive Medicine, Medical College of Shihezi University, Shihezi 832002, China

Funds:

National Natural Science Foundation of China 81560551

The Shihezi University Innovation Outstanding Young Talents Program CXPY202004

More Information

Corresponding author: GUO Shuxia, E-mail: gsxshzu@sina.com
Received Date: 2022-06-09
Rev Recd Date: 2022-09-22
Publish Date: 2023-04-10

Abstract

Abstract

Objective To analyze the prevalence of cardiovascular diseases (CVD) in the Uygur population in Xinjiang and its influencing factors, to provide a scientific basis for the future prevention and treatment of CVD. Methods A total of 16 321 Uyghur adults in two representative areas of Xinjiang in 2010 and 2016 were selected as the research subjects. Relevant data were collected through questionnaires, physical examinations, and biochemical tests. And CVD was chosen as the outcome event. Results A total of 16 321 people were investigated, the prevalence of CVD was 10.22%, and the standardized prevalence was 9.75%. The prevalence of females (12.88%) was higher than that of males (7.56%) (P < 0.001) and increased with age(P_trend < 0.001). Multivariate logistic regression analysis showed that CVD was related to age, female, married, BMI, larger waist circumference, hypertension, chronic kidney disease, hypertension and CVD family history, SBP, DBP, glutamyltransferase (GGT), and uric acid (UA). Conclusions The Uyghur population has a higher prevalence of CVD. Advanced age, female, married, obesity, larger waist circumference; hypertension, chronic kidney disease, hypertension, and CVD family history. Abnormal SBP, DBP, GGT, and UA are the risk factors for CVD. Traditional and non-traditional factors should be screened, and CVD prevention and treatment must be carried out according to the characteristics of the Uyghur population.
- Cardiovascular disease,
- Uygur,
- Influence factor

FullText(HTML)

References(29)

References

[1]	Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases writing group. global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol, 2020, 76(25): 2982-3021. DOI: 10.1016/j.jacc.2020.11.010.
[2]	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545. DOI: 10.3969/j.issn.1000-3614.2021.06.001. The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases burden in china: an updated summary of 2020[J]. Chinese Circulation Journal, 2021, 36(6): 521-545. DOI: 10.3969/j.issn.1000-3614.2021.06.001.
[3]	Poulter N. Global risk of cardiovascular disease[J]. Heart, 2003, 89 Suppl 2(Suppl 2): ii2-ii37. DOI: 10.1136/heart.89.suppl_2.ii2.
[4]	Tao J, Ma YT, Xiang Y, et al. Prevalence of major cardiovascular risk factors and adverse risk profiles among three ethnic groups in the Xinjiang Uygur Autonomous Region, China[J]. Lipids Health Dis, 2013, 12: 185. DOI: 10.1186/1476-511X-12-185.
[5]	Centers for Disease Control and Prevention(CDC). Cigarette smoking among adults--United States, 1992, and changes in the definition of current cigarette smoking[J]. MMWR Morb Mortal Wkly Rep, 1994, 43(19): 342-346.
[6]	Sun K, Ren M, Liu D, et al. Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies[J]. Clin Nutr, 2014, 33(4): 596-602. DOI: 10.1016/j.clnu.2013.10.003.
[7]	The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA project principal investigators[J]. J Clin Epidemiol, 1988, 41(2): 105-114. DOI: 10.1016/0895-4356(88)90084-4.
[8]	Alberico L Catapano, Ian Graham, Guy De Backer, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias[J]. European Heart Journal, 2016, 37(39): 2999-3058. DOI: 10.1093/eurheartj/ehw272.
[9]	刘力生. 中国高血压防治指南2010[J]. 中华高血压杂志, 2011, 19(8): 701-743. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGZ201108003.htm Liu LS. Chinese guidelines for the prevention and treatment of hypertension 201 0[J]. Chinese Journal of hypertension, 2011, 19(8): 701-743. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGZ201108003.htm
[10]	中国肥胖问题工作组. 中国成人超重与肥胖症预防与控制指南(节录)[J]. 营养学报, 2004, 26(1): 1-4. DOI: 10.3321/j.issn:0512-7955.2004.01.001. China Obesity working group. Guidelines for prevention and control of overweight and obesity in Chinese adults (excerpt)[J]. Acta Nutrimenta Sinica, 2004, 26(1): 1-4. DOI: 10.3321/j.issn:0512-7955.2004.01.001.
[11]	王新军, 于文. 2012年糖尿病诊疗指南——美国糖尿病协会[J]. 国际内分泌代谢杂志, 2012, 32(3): 4. DOI: 10.3760/cma.j.issn.1673-4157.2012.03.020. Wang XJ, Yu W. 2012 diabetes diagnosis and treatment guidelines-American Diabetes Association[J]. International Journal of Endocrinology and metabolism, 2012, 32(3): 4. DOI: 10.3760/cma.j.issn.1673-4157.2012.03.020.j.issn.1673-4157.2012.03.020.
[12]	Kong XL, Ma YC, Chen JH, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating glomerular filtration rate in the Chinese population[J]. Nephrol Dial Transplant, 2013, 28(3): 641-651. DOI: 10.1093/ndt/gfs491.
[13]	Chowdhury MZI, Haque MA, Farhana Z, et al. Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies[J]. Vasc Health Risk Manag, 2018, 14: 165-181. DOI: 10.2147/VHRM.S166111.
[14]	刘慧猛, 刘佳铭, 张眉, 等. 新疆农村地区2009-2012年维吾尔族人群高血压知识、态度和行为干预效果评价[J]. 中华高血压杂志, 2014, 22(8): 749-753. DOI: 10.16439/j.cnki.1673-7245.2014.08.001. Liu HM, Liu JM, Zhang M, et al. Effect of knowledge, attitude and behavior intervention on hypertension in a Xinjiang Uygur population in 2009-2012[J]. Chin J Hypertension, 2014, 22(8): 749-753. DOI: 10.16439/j.cnki.1673-7245.2014.08.001.
[15]	Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease[J]. Journal of Physiology, 2016, 594(8): 2061-2073. DOI: 10.1113/JP270538.
[16]	Sarink D, Nedkoff L, Briffa T, et al. Peeters A. Projected age- and sex-specific prevalence of cardiovascular diseases in Western Australian adults from 2005-2045[J]. Eur J Prev Cardiol, 2016, 23(1): 23-32. DOI: 10.1177/2047487314554865.
[17]	李建新, 秋丽雅. 我国少数民族人口生育及其影响因素分析——以壮族、回族、满族、维吾尔族、藏族、蒙古族为例[J]. 西北民族研究, 2022, (1): 139-155. DOI: 10.16486/j.cnki.62-1035/d.20220124.003. Li JX, Qiu LY. Analysis on fertility and its influencing factors of ethnic minorities in China -- Taking Zhuang, Hui, Manchu, Uygur, Tibetan and Mongolian as examples[J]. Journal of Northwestern Ethnic Studies, 2022, (1): 139-155. DOI: 10.16486/j.cnki.62-1035/d.20220124.003.
[18]	Appelman Y, van Rijn BB, Ten Haaf ME, et al. Sex differences in cardiovascular risk factors and disease prevention[J]. Atherosclerosis, 2015, 241(1): 211-218. DOI: 10.1016/j.atherosclerosis.
[19]	Pan XF, Wang LM, Pan A. Epidemiology and determinants of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(6): 373-392, DOI: 10.1016/S2213-8587(21)00045-0.
[20]	Wen B, Li H, Lu DR, et al. Genetic evidence supports demic diffusion of Han culture[J]. Nature, 2004, 431(7006): 302-305. DOI: 10.1038/nature02878.
[21]	Kachur S, Lavie CJ, de Schutter A, et al. Obesity and cardiovascular diseases[J]. Minerva Med, 2017, 108(3): 212-228. DOI: 10.23736/S0026-4806.17.05022-4.
[22]	Kita S, Maeda N, Shimomura I. Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome[J]. J Clin Invest, 2019, 129(10): 4041-4049. DOI: 10.1172/JCI129193.
[23]	王思佳, 李莉, 孙东晗, 等. BMI、腰围与睡眠质量对成年人高血压患病风险的联合作用[J]. 中华疾病控制杂志, 2022, 26(3): 257-262, 824. DOI: 10.16462/j.cnki.zhjbkz.2022.03.003. Wang SJ, Li L, Sun DH, et al. The combined effects of BMI, waist circumference, and sleep quality on the prevalence of hypertension in adults[J]. Chin J Dis Control Prev, 2022, 26(3): 257-262, 824. DOI: 10.16462/j.cnki.zhjbkz.2022.03.003.
[24]	厉玉婷, 赫英英, 刘国红, 等. 生命历程中饮酒暴露与农村居民高血压患病关系[J]. 中国公共卫生, 2015, 31(12): 1576-1579. DOI: 10.11847/zgggws2015-31-12-16. Li YT, He YY, Liu GH, et al. Relationship between life-course alcohol drinking and hypertension among rural adult residents in Shandong Province, China[J]. Chin J Public Health, 2015, 31(12): 1576-1579. DOI: 10.11847/zgggws2015-31-12-16.
[25]	He FJ, Tan M, Ma Y, et al. Salt Reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2020, 75(6): 632-647. DOI: 10.1016/j.jacc.2019.11.055.
[26]	北京高血压防治协会, 北京糖尿病防治协会, 北京慢性病防治与健康教育研究会, 等. 基层心血管病综合管理实践指南2020[J]. 中国医学前沿杂志(电子版), 2020, (8): 1-73. DOI: 10.12037/YXQY.2020.08-01. Beijing Hypertension Association, Beijing Diabetes Prevention and Treatment Association, Beijing Research for Chronic Diseases Control and Health Education, et al. Practice Guide for comprehensive management of cardiovascular diseases at the grassroots level 2020[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2020, (8): 1-73. DOI: 10.12037/YXQY.2020.08-01.
[27]	Matsushita K, Ballew SH, Coresh J. Cardiovascular risk prediction in people with chronic kidney disease[J]. Curr Opin Nephrol Hypertens, 2016, 25(6): 518-523. DOI: 10.1097/MNH.0000000000000265.
[28]	Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention[J]. Lancet, 2013, 382(9889): 339-352. DOI: 10.1016/S0140-6736(13)60595-4.
[29]	Kunutsor SK, Apekey TA, Khan H. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies[J]. Atherosclerosis, 2014, 236(1): 7-17. DOI: 10.1016/j.atherosclerosis.2014.06.006.